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INTRODUCTION 
Bovine viral diarrhea (BVD) is an infectious 
disease of cattle with a worldwide distribution (Rid-
path, 2010a), causing significant economic losses 
(Houe, 1999; Fourichon et al., 2005). Infections can 
be either persistent or transient. Persistently infected 
(PI) cattle are key in spreading and maintaining the 
infection within and between herds, as they conti-
nuously shed large amounts of BVD virus (BVDV) 
during their entire lives (Lindberg and Houe, 2005; 
Fulton et al., 2009). Therefore, most transient 
infections are caused by direct contact with PI cattle. 
The direct consequences of transient BVDV infection 
may vary from subclinical or mild disease to acute 
outbreaks with severe disease and high mortality. 
Moreover, transiently infected (TI) cattle may suffer 
from immunosuppression, which makes them more 
susceptible to secondary infections (Brackenbury et 
al., 2003; Ridpath, 2010b; Chase, 2013). Between 
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     SAMENVATTING
Het boviene virale diarreevirus (BVDV) is wereldwijd een van de meest belangrijke 
ziekteverwekkende virussen bij rundvee. Het virus is ook endemisch aanwezig in België. Omdat 
infectie met BVDV moeilijk te herkennen is aan de hand van de klinische verschijnselen alleen, is 
monitoring met behulp van diagnostische testen noodzakelijk om de aanwezigheid van het virus op een 
rundveebedrijf aan te tonen. Vaccinatie op zich is ontoereikend om BVDV uit te roeien. Een succesvolle 
controle vereist een combinatie van verschillende maatregelen. Aan de hand van een vragenlijst werd 
het BVDV-beleid op 241 geselecteerde Vlaamse rundveebedrijven onderzocht en dit leverde enkele 
opvallende resultaten op. Bij de meerderheid van de bedrijven was de BVDV-status niet bekend (63%) 
en slechts 23% van de bedrijven gebruikte een monitoringprogramma. Verder bleek dat zeven op tien 
veehouders (71%) voor vaccinatie kozen om BVDV te bestrijden zonder kennis te hebben van hun 
huidige BVDV-status.
A   BSTRACT
Bovine viral diarrhea virus (BVDV) is one of the most important viruses to cause disease in cattle 
worldwide. The virus is endemically present in Belgium. Clinical diagnosis of BVDV infection is 
difficult. Therefore, monitoring through testing is necessary to detect the presence of the virus on 
farms. As vaccination alone does not suffice for eradication, a combination of measures is required 
for successful control. Via a questionnaire, the BVDV policy on 241 selected Flemish cattle farms 
was investigated. This revealed some striking results. For the majority of the herds, the BVDV 
status was unknown (63%), and only 23% had a monitoring program in place. Furthermore, on 
seven out of ten (71%) BVDV-vaccinating farms, vaccination against BVDV was implemented as 
a strategy without knowing the actual BVDV status. 
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herds and animals, substantial differences in clinical 
presentation of BVDV infection have been noticed. 
This variability has been attributed to herds/animals 
having different immune statuses (Lindberg, 2003), 
or differences in strain virulence (Bolin and Ridpath, 
1992; Pellerin et al, 1994; Baule et al., 2001; Walz et 
al., 2001; Kelling et al., 2002). Because of the marked 
variation in clinical presentation, it is usually difficult 
to detect the presence of a BVDV infection in a herd by 
its clinical presentation alone (Lindberg and Alenius, 
1999; Ridpath, 2003; Evermann and Barrington, 
2005). As a result, monitoring by diagnostic testing 
for the presence of BVDV is vital to determine the 
herd status and for effective BVDV control. 
In the absence of a nationwide eradication pro-
gram in Belgium, control is typically performed at 
the herd level by decision of the farmer. Meticulous 
tracing, correct administration (Laureyns et al., 2010) 
and the implementation of the key principles of 
BVDV control as stated by Lindberg and Houe (2005) 
are essential to successfully control BVDV at the 
herd level. These principles are: stringent biosecurity, 
the detection and removal of PI cattle, continuous 
monitoring and the potential implementation of 
vaccination. As the prevalence of BVDV infection 
at the farm level is high in Belgium (Sarrazin et al., 
2013), biosecurity measures are highly important to 
protect herds against BVDV (re)infection. Therefore, 
the implementation of biosecurity measures has to 
be the first step in BVDV control in Belgium. Most 
importantly, PI animals should be removed from the 
herd, as they play the key role in the transmission of 
BVDV by continuous shedding of infectious virus 
(Lindberg and Houe, 2005). In BVDV-free herds, 
longitudinal surveillance should be combined with 
biosecurity enhancements to detect and prevent 
potential (re)infection, and allow prompt action in 
the event of disease incursion. Monitoring can be 
performed using serological spot tests (Houe, 1994; 
Booth and Brownlie, 2012), and has to be continued 
as long as BVDV is present in the region. Although 
not 100% effective in protecting every individual 
animal, vaccination can be an essential component 
of a herd level control program (Ridpath, 2012). 
However, if eradication is to be achieved, vaccination 
must be combined with the other three principles of 
BVDV control (Lindberg and Houe, 2005; Rodning 
et al., 2010; Booth and Brownlie, 2012). 
Although it has been emphasized in many publi-
cations that BVDV control requires a combination of 
different, strictly executed measures, little information 
is available on how these recommendations are 
implemented in the field. This study highlights the 
BVDV management on Flemish farms.
MATERIAL AND METHODS
In 2011, a large multicenter study was conducted 
(Pfeiffer et al., 2012) to identify calf-level factors 
associated with bovine neonatal pancytopenia (BNP) 
on BNP-affected farms (Jones et al., 2013), and 
herd-level factors that explained why some farms 
experienced cases of BNP and others did not. Since 
BNP has been hypothesized to be associated with 
BVDV vaccination, a substantial part of the interview 
was on BVDV management. Questions of relevance 
for the present study were selected from the BNP 
questionnaire and are presented in Table 1. 
The Belgian contribution took place in the Flemish 
speaking part of the country, Flanders, and was 
conducted by the Faculty of Veterinary Medicine of 
Ghent University in cooperation with the Flemish 
Animal Health Organization “Dierengezondheidszorg 
Vlaanderen” (DGZ). Through a call on the website 
of DGZ and notifications in veterinary and farmer 
magazines, veterinarians and farmers were encouraged 
to report suspected BNP cases. Case farms were 
visited for sample collection, and a questionnaire was 
used to interview the farmers on colostrum feeding, 
cattle health management, disease management and 
medication use. Farms where the veterinarian had 
reported a suspicion of BNP, were classified as case 
farms. The latter farms belonged to the clientele of the 
same veterinaty practice, and had never been diagnosed 
with BNP before. The control farms were of the same 
type and approximately the same size as the case 
farms. Farmers of the control farms were interviewed 
by telephone, using the same questionnaire. All of 
the herd managers of the case and control farms were 
interviewed by the first author. Data of 241 Flemish 
farms was available for the study.
 The recognition of BVDV infection by its clinical 
presentation alone is very difficult, if not impossible. 
Therefore, in this study a herd was only considered 
BVDV-free if the status was based on a test-and 
cull-program or a herd test. A test-and-cull program 
consists of virological testing by PCR or antigen-
ELISA of all cattle in the herd followed by the culling 
of PI animals. In the present study, the continuous 
testing of all newborns by antigen-ELISA for already 
more than one year, or regular serological spot tests 
of which the last one took place within the last 
twelve months, were both accepted as a herd test. 
The intention of using a spot test is to detect BVDV 
circulation in a herd by testing five to ten blood 
samples of young stock between eight and twelve 
months old for the presence of BVDV antibodies 
(Houe, 1992).
RESULTS
The results are summarized in Table 2. The farmers 
were asked ‘Was the herd BVDV-free for the last 12 
months?’. Of the 241 herds, 82 had a known BVDV 
status that was based on testing; 66 of those 82 had 
been BVDV-free and 16 had been BVDV-infected 
during the past year. On 158 of the farms (66%), there 
had been no monitoring for BVDV. When the farmers 
of the herds that were BVDV-free, were asked for 
how long they had held this status, eleven of the herd 
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managers communicated a date within the last twelve 
months, although they scored their herd BVDV-free 
for the whole of the preceding twelve months in 
another answer.
 On 55 (67%) of the 82 herds with known BVDV 
status (infected and free farms), BVDV testing 
consisted of a herd test while on the other 27 farms, a 
test-and-cull method was in use. 
On the question ‘Did you have a confirmed PI 
animal on your farm within the past twelve months?’, 
twenty of the 241 herd managers answered positively 
(8%), whereas the majority (153) did not know 
whether a PI animal had been on the farm or not, as 
they declared that a monitoring program for BVDV 
had not been in place (63.5%). On 68 (28%) of the 
herds, the BVDV status was known, but no PI animals 
had been detected within the last twelve months. 
On 155 (64.5%) of the 241 farms, a BVDV vacci-
nation program had been in use  during the past 12 
months or earlier. When asked for the ‘Reason for 
starting this vaccination’, there was one blank result, 
and 83 of the 155 herd managers (53.5% of all of 
the vaccinating herds) answered that a vaccination 
strategy had been started because of a BVDV problem; 
55 (35.5% of all of the vaccinating herds) had started 
the vaccination to prevent BVDV problems. When 
examining the names of BVDV vaccines used in the 
different age categories, on 42 of the 155 vaccinating 
herds, only young stock under six months of age 
appeared to be vaccinated, all with a trivalent vaccine 
containing a BVDV component (Rispoval®3-BRSV-
Pi3-BVD, Pfizer Animal Health). Of these 42 herd 
managers, only 16 declared that the reason for applying 
Rispoval®3-BRSV-Pi3-BVD vaccination had been 
purely for the prevention of respiratory disease. On 
93 farms, the vaccination of heifers and/or adults 
Table 1. Questions of the bovine neonatal pancytopenia questionnaire selected for the present study.
Question Possible Answer
 
Production type mixed 
 dairy  
 beef
Veterinarian  code number
Total number of cattle at the time of
the interview (young stock included) 
Vaccinations within the last 12 months: BVDV
 
 calves up to 6 months           name of vaccine
 young stock > 6m                 name of vaccine
 breeding heifers                    name of vaccine
 mature cows                          name of vaccine
Was the herd BVDV-free during the last yes - indicate date since when BVD-free
12 months? no
 unknown
How has the herd status been determined? control program 
 test-and-cull 
 herd test 
Have you had a confirmed BVDV yes
animal (PI) on your farm within no
the last 12 months? not monitoring for PI
Was there a BVDV vaccination program? yes
 no 
Reason for starting vaccination: had a BVDV problem on farm
 to prevent the farm from having a BVDB problem              
 unknown status
 others 
Currently still vaccinating against BVDV? yes
 no
Which BVDV vaccine is currently used? 
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was still continued at the time of the interview (farms 
that only vaccinated young stock were excluded); 66 
of these 93 (71%) herd managers did not know the 
BVDV status of their herds. 
Of the twenty herds where a PI animal had been 
found within the previous twelve months, seven 
farmers applied the BVDV vaccination of adult cattle 
at the time of the interview. Of these seven herds, five 
had been vaccinated for two years or longer.
DISCUSSION
The main objective of this study was to investigate 
the BVDV management on selected farms by 
describing common policies for PI animal detection 
and monitoring, two of the three essential BVDV 
control measures. The results were collected as part 
of a larger case-control study on the identification 
of risk factors for the occurrence of BNP, a BVDV 
vaccination related disease (Jones et al., 2013). 
The fact that all of the questions for this study 
were asked by the same person, both on case 
and control farms, reduced the likelihood of bias 
inclusion. Although the same questionnaire was used 
for both case and control farms, on the case farms, 
the interviews occurred face to face, whereas on the 
Table 2. Descriptive data on some aspects of the bovine viral diarrhea (BVDV) management on 241 Flemish cattle herds.
            Herd type
 Dairy Beef Mixed Overall
Herd information (n=241)
    
Number of herds  113 72 56 241
Number of veterinary practices involved     43
Average number of animals per herd  142 (46-450) 131 (4-380) 192 (50-530) 150 (4-530)
Questions on knowledge of BVDV status    
1. Was the herd BVDV-free during the last 12 months?    
          Answer                 yes 27 22 17 66  (27%)
           no 8 3 5 16  (7%)
           unknown 78 46 34 158 (66%)
           no answer    1
Herds with known BVDV-status 35 25 22 82 (34%)
    
2. If BVDV-free, on what basis is this      determined?    
               Test-and-cull program 11 9 7 27/82 (33%)
               herd test (monitoring) 24 17 14 55/82 (67%)
3.Had a PI within the last 12 months    
               yes 10 5 6 20 (8.5%)
               no 28 22 18 68 (28%)
               not monitoring for BVDV 75 46 32 153  (63.5%)
4. Had a vaccination program during last 5 years?    
           yes 63 48 44 155 (64.5%)
           no 50 23 12 85 (35%)
           no answer    1
    
Subset of data: BVD-vaccinating herds (n=155)    
    
Vaccination only of cattle <1y     42 (27%)
Reason for starting vaccination    
           had a BVDV problem in herd 37 26 20 83 (53.5%)  
           to prevent BVDV problems 24 13 18 55 (35.5%)
           others 2 9 5 16 (10.5%)  
           no answer      1 
    
Subset of data : herds still BVD vaccinating at the time of the interview (n=93)
    
Still vaccinating adult cattle     93
Still vaccinating adult cattle and 
                 BVDV status unknown      66 (71%)
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control farms, they were conducted by telephone. 
Therefore, the answers collected on the case farms 
might be considered more reliable, as they were better 
supported by written or electronically stored data such 
as lab results provided by the farmer at the herd visit. 
Two different descriptions of the same question 
indicated that the BVDV status was unknown on 
66% (n=158) and 63.5% (n=153) of the farms during 
the past year, respectively referring to the absence 
of BVDV and the presence of a PI animal. The fact 
that there was little difference between the figures 
obtained via both questions reinforces the certainty 
that the majority of the herd managers did not 
know the BVDV status of the herd. It is interesting 
to note that when asked if they knew their BVDV 
status, 16 farm managers answered that their herds 
had been infected in the last 12 months. Yet, when 
asked about the presence of PI animals, twenty farm 
managers stated that PIs had been identified on their 
premises in the last twelve months. Remarkably, four 
farmers did not appear to know that the presence of 
PI animals is an indicator of herd-level infection. 
Moreover, when asked for how long their herds had 
been BVD-free, eleven herd managers communicated 
a date within the last twelve months, although they 
had previously scored their herds BVDV-free for 
the whole of the preceding twelve months. These 
examples demonstrate that a question may produce 
different answers when asked in a different way, and 
illustrate potential difficulties when working with 
questionnaires.
Interestingly, two veterinary practices of the 43 
involved were responsible for 16 of the 55 herds with 
BVDV surveillance. This result suggests that few 
veterinary practices implement BVDV monitoring in 
their herd health management programs. 
Farms were not classified as BVDV-free if this 
status was obtained from clinical signs. The only 
methods accepted for defining the BVDV status 
were: a herd test or a test-and-cull program during 
the last year. Of the 82 herds with known BVDV 
status, those 27 where a test-and-cull program had 
been used, may not necessarily be considered as herds 
with BVDV surveillance. On these farms, the herd 
managers had performed one whole herd test for the 
presence of PI animals during the last year, reacting 
on a suspicion of BVDV infection, and afterwards 
assumed that the herd had been BVDV-free since 
then. The only methods that may be considered as 
surveillance are regular serological spot tests or 
virological testing of all newborn calves on a whole 
blood sample from the age of two months onwards. 
Ear notch testing (Kuhne et al., 2005; Hill et al., 2007) 
may be an alternative, but was not yet available in 
Flanders at the time the study was conducted. It can 
be concluded that only 23% (n=55) of all the herds 
implemented a BVDV surveillance program in the 
strictest sense. Nevertheless, virological testing of 
all newborns as a sole monitoring measure might 
not rapidly identify re-infection of the herd (Houe et 
al., 2006), for instance because of overlooking a PI 
calf due to an administrative failure (Laureyns et al., 
2010), a false negative result (Presi et al., 2011; Fux 
and Wolf, 2012) in the previous detection and removal 
of PI cattle or external re-infection. This is especially 
true if testing all newborns has only been conducted 
for a short period of time, and does not follow a test-
and-cull program, since PI animals can effectively 
remain within a herd until the point at which they 
calve.
The BNP case farms were all BVDV-vaccinated, 
and the corresponding controls were linked to the same 
veterinary practice. Therefore, it can be supposed 
that the veterinarians involved were conscious of 
the importance of BVDV infection, because they 
had advised vaccination to their clients. On the other 
hand, it appeared that most of them did not apply all 
principles of BVDV control (Lindberg and Houe, 
2005), as on 71% of those farms still vaccinating at 
the moment of the interview, the BVDV status was 
unknown. This raises the question as to whether the 
veterinary profession as a whole still has an over-
reliance on BVDV vaccination for control of the 
disease, when it should be considered as only one 
component of a range of control measures that should 
be implemented.
As the multi-country study was focused on BNP, 
a BVDV vaccination-related disease, the number of 
vaccinating herds may have been overestimated. Most 
likely, the control group had been vaccinated as well, 
since it was recruited from the same veterinary practice 
as the case herds, and consequently, the same BVDV 
control strategy may have been implemented. On the 
other hand, at the time of the herd visit, most of the 
farmers had already been informed on BNP. Some had 
changed to another BVDV vaccine, whereas twenty of 
the original 155 vaccinating herd managers had ceased 
vaccination at the time of the interview, most likely for 
fear of BNP. As a result, the figures are not suited to 
interpret the BVDV vaccination prevalence in Flanders. 
They rather show some shortcomings of vaccination 
management. Although vaccination on its own is not 
sufficient to eradicate BVDV from a herd (O’ Rourke, 
2002; Booth and Brownlie, 2012; Ridpath, 2013), 66 
of the 93 herd managers who were still vaccinating 
against BVDV at the time of the interview, did not 
know their BVDV status (71%). Vaccination should be 
combined with all three other necessary components 
of BVDV control: biosecurity measures, the detection 
and removal of PI animals, and monitoring (Lindberg 
and Houe, 2005). Moreover, it should be realized 
that the use and application of BVDV vaccines in the 
field are not always correct (Meadows, 2010). The 
present study shows that in almost one third of all 
the vaccinating herds (27%; n=42), only young stock 
under six months of age had been vaccinated, while the 
advice is to reach a 100% coverage of the adult herd 
(Lindberg and Houe, 2005) with the main objective of 
preventing infection of pregnant cattle. 
On 83 of the 155 vaccinating herds (53.5%), the 
decision of starting BVDV vaccination was made at 
the occurrence of a BVDV problem. Another 10% 
Vlaams Diergeneeskundig Tijdschrift, 2013, 83 361
(n=16) of the herd managers did not really have the 
intention to control BVDV. They used a trivalent 
vaccine containing a BVD-component, to protect 
calves from bovine respiratory disease (Rispoval®3-
BRSV-Pi3-BVD Pfizer Animal Health), but did not 
have a BVDV vaccination program for older cattle. 
Not surprisingly, among these 16, there was only 
one dairy herd and 15 beef farms, since Belgian 
Blue cattle, the predominant beef breed in Belgium, 
are substantially more susceptible to respiratory 
disease than dairy breeds (Bureau et al., 1999). 
Nevertheless, 42 of the farmers vaccinated only 
three-month-old calves. Since only 16 farmers stated 
that they vaccinated against respiratory disease, it 
can hence be assumed that 26 other herd managers 
considered vaccinating only three-month-old calves 
as a herd level BVDV control strategy. 
Only 35.5% (n=55) of the vaccinating farmers 
stated to have started the vaccination program to 
protect the herd from BVDV infection without 
previous BVDV problems. Obviously, both these 
farmers and the ones who started vaccination after 
their herds had suffered from BVD problems (53.5%), 
i.e. the majority of vaccinating farmers, must have 
been aware of the economic consequences of BVDV 
infection. 
Finally, the observation that a PI animal had 
been detected on five farms, despite BVDV vacci-
nation during the last two years or longer, shows 
that continuous monitoring is necessary, even for 
vaccinating herds. 
CONCLUSION
This study illustrates that even on selected farms, 
where many farmers were willing to vaccinate against 
BVDV and thus conscious of the impact of BVDV 
infection, the necessary elements of BVDV control 
were insufficiently implemented. In particular, too 
many control strategies were based on vaccination 
alone and only few herds were monitored for BVDV. 
These findings suggest that on many Flemish farms, 
BVDV control remains incomplete and consequently 
inefficient, despite repeated communication and 
education from regional animal health services and 
veterinary faculties. It is up to the veterinarians to 
train their clients to control BVDV efficiently. 
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